Search All UT System Experts

Combined autophagy and proteasome inhibition a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma

Dan T. Vogl, Edward A. Stadtmauer, Kay See Tan, Daniel F. Heitjan, Lisa E. Davis, Laura Pontiggia, Reshma Rangwala, Shengfu Piao, Yunyoung C. Chang, Emma C. Scott, Thomas M. Paul, Charles W. Nichols, David L. Porter, Janeen Kaplan, Gayle Mallon, James E. Bradner, Ravi K. Amaravadi

Research output: Contribution to journal › Article › peer-review

301 Scopus citations

Fingerprint

Dive into the research topics of 'Combined autophagy and proteasome inhibition a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences